CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 299 enrolled
Drug / intervention
As per clinical practiceother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00794118
NCT00794118N/ACompleted
CompareCT.gov

Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study

Pfizer·observational·Posted Nov 19, 2008·Updated Jul 1, 2019

In Brief

An observational study evaluating As per clinical practice for Rheumatoid Arthritis. Completed, enrolled 299 participants across 1 site.

Detailed Summary

The primary purpose of this observational study is to describe and define the current daily practice of management of anti-TNF-agents in Rheumatoid Arthritis (RA) patients. Data will be collected only from subjects providing informed consent.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 19, 2008
Enrollment StartJun 1, 2008
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 17.6 years ago

Interventions

As per clinical practiceother

As per clinical practice